239 related articles for article (PubMed ID: 32653550)
1. Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?
Bendjelid K; Giraud R; Von Düring S
Anaesth Crit Care Pain Med; 2020 Aug; 39(4):451-452. PubMed ID: 32653550
[No Abstract] [Full Text] [Related]
2. Almitrine as a non-ventilatory strategy to improve intrapulmonary shunt in COVID-19 patients.
Losser MR; Lapoix C; Delannoy M; Champigneulle B; Payen D
Anaesth Crit Care Pain Med; 2020 Aug; 39(4):467-469. PubMed ID: 32505756
[No Abstract] [Full Text] [Related]
3. Effect of almitrine bismesylate and inhaled nitric oxide on oxygenation in COVID-19 acute respiratory distress syndrome.
Cardinale M; Esnault P; Cotte J; Cungi PJ; Goutorbe P
Anaesth Crit Care Pain Med; 2020 Aug; 39(4):471-472. PubMed ID: 32505755
[No Abstract] [Full Text] [Related]
4. Efficacy of Almitrine in the Treatment of Hypoxemia in Sars-Cov-2 Acute Respiratory Distress Syndrome.
Barthélémy R; Blot PL; Tiepolo A; Le Gall A; Mayeur C; Gaugain S; Morisson L; Gayat E; Mebazaa A; Chousterman BG
Chest; 2020 Nov; 158(5):2003-2006. PubMed ID: 32512007
[No Abstract] [Full Text] [Related]
5. Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?
Caocci G; La Nasa G
Ann Hematol; 2020 Jul; 99(7):1675-1676. PubMed ID: 32405693
[No Abstract] [Full Text] [Related]
6. Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS).
Altschuler EL; Kast RE
Med Hypotheses; 2020 Aug; 141():109774. PubMed ID: 32344275
[No Abstract] [Full Text] [Related]
7. Unexpected BP Sensitivity to Angiotensin II in a Patient With Coronavirus Disease 2019, ARDS, and Septic Shock.
Wang H; Das S; Wieruszewski PM; Taji J; Bartlett B; Azad N; Chowdhury A; Kolar GJ; Jain N; Subla MR; Khan SA
Chest; 2020 Aug; 158(2):e55-e58. PubMed ID: 32335068
[TBL] [Abstract][Full Text] [Related]
8. P-selectin blockade in COVID-19-related ARDS.
Neri T; Nieri D; Celi A
Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1237-L1238. PubMed ID: 32464083
[No Abstract] [Full Text] [Related]
9. Case 18-2020: A 73-Year-Old Man with Hypoxemic Respiratory Failure and Cardiac Dysfunction.
Kazi DS; Martin LM; Litmanovich D; Pinto DS; Clerkin KJ; Zimetbaum PJ; Dudzinski DM
N Engl J Med; 2020 Jun; 382(24):2354-2364. PubMed ID: 32521138
[No Abstract] [Full Text] [Related]
10. Thrombolysis restores perfusion in COVID-19 hypoxia.
Arachchillage DJ; Stacey A; Akor F; Scotz M; Laffan M
Br J Haematol; 2020 Sep; 190(5):e270-e274. PubMed ID: 32735730
[No Abstract] [Full Text] [Related]
11. Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?
Cadegiani FA
Am J Physiol Endocrinol Metab; 2020 May; 318(5):E587-E588. PubMed ID: 32297520
[No Abstract] [Full Text] [Related]
12. Treating hypoxemic patients with SARS-COV-2 pneumonia: Back to applied physiology.
Bendjelid K; Raphaël G
Anaesth Crit Care Pain Med; 2020 Jun; 39(3):389-390. PubMed ID: 32305591
[No Abstract] [Full Text] [Related]
13. Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166.
Quesada-Gomez JM; Entrenas-Castillo M; Bouillon R
J Steroid Biochem Mol Biol; 2020 Sep; 202():105719. PubMed ID: 32535032
[TBL] [Abstract][Full Text] [Related]
14. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.
Zhou W; Liu Y; Tian D; Wang C; Wang S; Cheng J; Hu M; Fang M; Gao Y
Signal Transduct Target Ther; 2020 Feb; 5(1):18. PubMed ID: 32296012
[No Abstract] [Full Text] [Related]
15. Anticoagulants and immunosuppressants in COVID-19: Bullets to Defeat MicroCLOTS.
Turi S; Nardelli P; Landoni G
Ann Card Anaesth; 2020; 23(3):258-259. PubMed ID: 32687078
[No Abstract] [Full Text] [Related]
16. Fibrinolytic therapy in patients with COVID-19 and acute respiratory distress syndrome: Is this a feasible approach?
Savioli F; Rocha L; Góis A; Nakano LC
J Trauma Acute Care Surg; 2020 Dec; 89(6):e187-e188. PubMed ID: 32868539
[No Abstract] [Full Text] [Related]
17. Almitrine Infusion in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Acute Respiratory Distress Syndrome: A Single-Center Observational Study.
Caplan M; Goutay J; Bignon A; Jaillette E; Favory R; Mathieu D; Parmentier-Decrucq E; Poissy J; Duburcq T;
Crit Care Med; 2021 Feb; 49(2):e191-e198. PubMed ID: 33093279
[TBL] [Abstract][Full Text] [Related]
18. COVID-19-related Acute Respiratory Distress Syndrome: Not So Atypical.
Bos LDJ
Am J Respir Crit Care Med; 2020 Aug; 202(4):622-624. PubMed ID: 32579026
[No Abstract] [Full Text] [Related]
19. Risk of COVID-19 disease in the elderly population and physiotherapy.
Özkeskin M; Elibol N; Bakırhan S
Physiotherapy; 2020 Sep; 108():76-77. PubMed ID: 32717618
[No Abstract] [Full Text] [Related]
20. Efficacy of almitrine as a rescue therapy for refractory hypoxemia in COVID and non-COVID acute respiratory distress syndrome. A retrospective monocenter study.
Blot PL; DE Roquetaillade C; Deniau B; Gaugain S; Kindermans M; Julian N; LE Dorze M; Mebazaa A; Chousterman BG; Barthélémy R
Minerva Anestesiol; 2023 Mar; 89(3):157-165. PubMed ID: 36287391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
